Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s New ‘N of 1’ Guidance Essentially A Down Payment On Critical Advice
05 Jan 2021
•
By
Sarah Karlin-Smith
More from Cell & Gene Therapies
More from Advanced Technologies